Australia - English - Department of Health (Therapeutic Goods Administration)

bioq pharma pty ltd - ropivacaine hydrochloride monohydrate, quantity: 2.116 mg/ml (equivalent: ropivacaine hydrochloride, qty 2 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - ropivacaine readyfusor (0.2% ropivacaine solution for injection) is indicated for: ? continuous peripheral nerve block infiltration for postoperative pain management in adults ? continuous wound infiltration for postoperative pain management in adults,(data for peripheral nerve block administered as a continuous peripheral infusion and for continuous wound infusion support the use for up to 48 hours only).

Australia - English - Department of Health (Therapeutic Goods Administration)

bioq pharma pty ltd - 62713 - mechanical infusion pump kit, medicated - the readyfusor system is a non-electric pre-filled infusion kit that has been designed for point of care use for continuous peripheral nerve infiltration or continuous wound infiltration only, for patients requiring continuous wound infusion with ropivacaine.

Australia - English - Department of Health (Therapeutic Goods Administration)

bioq pharma pty ltd - 16117 - mount, - propofol weight dose dispenser system comprising of propofusor 1% and a carabiner dispenser mount. the mount is intended to support or suspend the propofusor 1% during administration.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bioq pharma limited, united kingdom - ropivacaine - solution for infusion - 2 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

bioq pharma b.v. - ropivacaine hydrochloride monohydrate - solution for infusion in administration system - 10 milligram(s)/hour - amides; ropivacaine

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bioquell uk limited - perÓxido de hidrogeno - perÓxido de hidrogeno....35 g

Australia - English - Department of Health (Therapeutic Goods Administration)

bioq pharma pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: egg lecithin; soya oil; water for injections; glycerol; sodium hydroxide - induction of general anaesthesia in adults,propofusor 1% is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults.,maintenance of general anaesthesia in adults,propofusor 1% is a short-acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults.,propofusor 1% has no analgesic properties.,sedation during intensive care in adults,propofusor 1% may also be used in adults for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures in adults,propofusor 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

United States - English - NLM (National Library of Medicine)

bioq pharma incorporated - ropivacaine hydrochloride anhydrous (unii: 35504lbe2t) (ropivacaine - unii:7io5lya57n) -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ecolab pty ltd - hydrogen peroxide - other liquids to be applied undiluted - hydrogen peroxide ungrouped active 395.0 g/l - disinfectant